Tinospora Cordifolia Stem And Root Extract
Also known as: Tinospora cordifolia (Willd.) Miers, Guduchi, Giloy, Tinospora cordifolia
Overview
Tinospora cordifolia, commonly known as Guduchi or Giloy, is a climbing shrub native to the Indian subcontinent and widely used in traditional Ayurvedic medicine. The stem and root extracts are used in supplements for their purported immunomodulatory, anti-inflammatory, hepatoprotective, and antioxidant properties. It has gained attention for potential applications in managing infectious diseases, liver protection, and immune support. Research includes in vitro, animal, and human studies, with some clinical trials and systematic reviews emerging recently, particularly in the context of tuberculosis treatment and COVID-19 management. The evidence base is growing but remains mixed, with some promising findings on efficacy balanced by emerging safety concerns, especially related to hepatotoxicity. The quality of clinical evidence varies, with few large-scale, high-quality randomized controlled trials (RCTs) and some systematic reviews/meta-analyses available.
Benefits
Tinospora cordifolia has demonstrated several potential benefits: * **Immunomodulatory effects:** Studies show it enhances immune function by modulating cytokine production and boosting macrophage and natural killer cell activity. This supports its traditional use as an immune booster and its investigation in COVID-19 management. * **Hepatoprotective effects:** Clinical and preclinical studies suggest it may protect against liver injury, including drug-induced liver injury (DILI) in tuberculosis patients. A systematic review found that a combination of turmeric plus T. cordifolia may reduce anti-TB drug-induced liver injury. * **Anti-inflammatory and antioxidant effects:** Experimental studies show it reduces oxidative stress and inflammation markers, potentially contributing to therapeutic effects in chronic diseases. * **Potential antiviral activity:** In silico and experimental studies suggest phytochemicals in T. cordifolia may interact with viral proteins, supporting its investigation in COVID-19 treatment, though clinical evidence is limited. * **Cancer-related effects:** Some meta-analyses suggest anti-cancer potential in vitro and in animal models, but human clinical data are insufficient.
How it works
Tinospora cordifolia exerts its effects through several mechanisms. It modulates both innate and adaptive immunity by enhancing macrophage activation, increasing phagocytosis, and regulating cytokines such as IL-6, TNF-α, and interferons. It also scavenges free radicals and upregulates endogenous antioxidant enzymes, reducing oxidative stress. For hepatoprotection, the extract may stabilize hepatocyte membranes, reduce inflammatory infiltration, and modulate liver enzymes. Key bioactive constituents include alkaloids (e.g., tinosporine), diterpenoid lactones, glycosides, and polysaccharides. Limited data exists regarding absorption and bioavailability of these active compounds, which may vary depending on extraction method and formulation.
Side effects
While historically considered safe in traditional use and short-term clinical studies, recent reports indicate a risk of herb-induced liver injury (HILI). More than 50 cases of clinically apparent acute liver injury linked to T. cordifolia have been reported since 2017, mostly from India and Thailand, with some fatal outcomes. The injury is typically hepatocellular with marked elevations in ALT and AST (10-50 times upper limit), variable hyperbilirubinemia, and sometimes autoimmune features on biopsy. Latency ranges from weeks to months. This risk appears increased with prolonged use and in patients with preexisting liver disease. Common side effects are generally uncommon; mild gastrointestinal discomfort occasionally reported. Potential interactions with immunosuppressants or hepatotoxic drugs are possible but not well studied. Use with caution in patients with liver disease or those at risk of liver injury. Limited safety data in pregnant or breastfeeding women, children, and those with chronic illnesses.
Dosage
Clinical trials vary, but typical doses of stem/root extracts range from 300 mg to 1000 mg daily in divided doses; however, standardized dosing is lacking. Optimal dosage is not well established due to variability in extract preparations and limited high-quality clinical trials. The maximum safe dose is unknown, but hepatotoxicity cases suggest caution with high or prolonged dosing. It is often administered orally, with or without food. Extracts standardized for bioactive compounds may offer more consistent effects. Co-administration with food or other herbs may affect bioavailability. There are no specifically identified required cofactors.
FAQs
Is Tinospora cordifolia safe for long-term use?
Recent evidence indicates a potential risk of liver injury with prolonged use; monitoring liver function is advisable if used long-term.
Can it be used to prevent or treat COVID-19?
Preliminary studies suggest potential immunomodulatory benefits, but robust clinical evidence is lacking to support its use for COVID-19 prevention or treatment.
Does it interact with other medications?
Possible interactions are not well characterized; caution is advised, especially with hepatotoxic or immunosuppressive drugs.
How soon can benefits be expected?
Effects on immune markers may be seen within weeks; clinical benefits depend on the condition being treated and individual response.
Is it effective for liver protection?
Some evidence supports protective effects against drug-induced liver injury, but safety concerns complicate recommendations. Use with caution and monitor liver function.
Research Sources
- https://pubmed.ncbi.nlm.nih.gov/37963954/ – This systematic review and network meta-analysis of RCTs involving TB patients found that a combination of turmeric plus T. cordifolia and NAC showed benefit in preventing anti-TB DILI, suggesting hepatoprotective potential. The authors noted heterogeneity in study designs and herbal formulations, and safety outcomes were variably reported.
- https://www.ncbi.nlm.nih.gov/books/NBK608429/ – This NCBI LiverTox case review analyzed case reports and clinical data and established causality for clinically apparent liver injury with hepatocellular pattern, autoimmune features, and some fatalities related to T. cordifolia. The review is based mostly on observational data, and causality was based on clinical criteria.
- https://sciencescholar.us/journal/index.php/ijhs/article/view/10812 – This systematic review included RCTs, animal studies, and in silico analyses and found promising immunomodulatory and antiviral effects of T. cordifolia in the context of COVID-19. The authors noted that clinical efficacy is not conclusively established due to small sample sizes, heterogeneity, and a lack of large RCTs.
- https://pmc.ncbi.nlm.nih.gov/articles/PMC3644751/ – This narrative review of 175 articles including in vitro, animal, and human studies found broad pharmacological effects including immunomodulation, antioxidant, anti-inflammatory, and hepatoprotective activities of T. cordifolia. The authors noted that the data is mostly preclinical, and clinical trials are limited.
- https://jrasb.com/index.php/jrasb/article/view/665 – This article was not directly cited in the text, and therefore a summary cannot be provided. A URL was extracted from the citation text.